Polymyxin encompasses a group of cationic polypeptide antibiotics derived from the bacterium Bacillus polymyxa, commonly utilized to treat severe, multidrug-resistant Gram-negative bacterial infections.… Read more












Polymyxin encompasses a group of cationic polypeptide antibiotics derived from the bacterium Bacillus polymyxa, commonly utilized to treat severe, multidrug-resistant Gram-negative bacterial infections. These agents exert bactericidal effects by disrupting bacterial cell membranes. This category provides essential reference standards for Polymyxin B, E, and their related components, which are indispensable for precise analytical testing and rigorous quality control. Pharmaceutical laboratories use these high-quality materials for impurity profiling, allowing for the accurate identification and quantification of impurities and metabolites that may arise during synthesis or storage. Furthermore, stable isotope labelled compounds are available as internal standards for mass spectrometry applications, facilitating reliable method validation and ensuring the integrity of the active pharmaceutical ingredient throughout the drug development and manufacturing lifecycle.